In a mouse melanoma regression model, immunotherapy with immune checkpoint inhibitors (ICIs) (e.g., anti-CTLA-4, anti-PD-1 or their combination) increased intratumor neutrophil counts and induced NET-like formation [22]. This evidence concerns the gene PDCD1 and melanoma.